Australia markets open in 8 hours 4 minutes

Entheon Biomedical Corp. (ENTBF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.0279+0.0055 (+24.78%)
As of 09:30AM EST. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 1.11M
Enterprise value 921.25k
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)12.91
Price/book (mrq)0.20
Enterprise value/revenue 8.77
Enterprise value/EBITDA -0.16

Trading information

Stock price history

Beta (5Y monthly) 0.23
52-week change 3-94.51%
S&P500 52-week change 3-13.20%
52-week high 30.4350
52-week low 30.0140
50-day moving average 30.0267
200-day moving average 30.0610

Share statistics

Avg vol (3-month) 320.21k
Avg vol (10-day) 349.78k
Shares outstanding 559.09M
Implied shares outstanding 6N/A
Float 855.94M
% held by insiders 18.63%
% held by institutions 10.07%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 311 Nov 2020
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in CAD.

Fiscal year

Fiscal year ends 29 Nov 2021
Most-recent quarter (mrq)30 Aug 2022

Profitability

Profit margin 0.00%
Operating margin (ttm)-6,027.18%

Management effectiveness

Return on assets (ttm)-46.31%
Return on equity (ttm)-54.69%

Income statement

Revenue (ttm)105.06k
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)1,084.30%
Gross profit (ttm)9.13k
EBITDA -6.71M
Net income avi to common (ttm)-4.55M
Diluted EPS (ttm)-0.1060
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)248.38k
Total cash per share (mrq)0
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)9.35
Book value per share (mrq)0.11

Cash flow statement

Operating cash flow (ttm)-3.14M
Levered free cash flow (ttm)-2.43M